Kidney Stone and Doctor With Family - Primary Hyperoxaluria Type 1 (PH1) Testing
Kidney Stone and Doctor With Family - Primary Hyperoxaluria Type 1 (PH1) Testing

TESTING FOR PRIMARY HYPEROXALURIA TYPE 1 (PH1)

Diagnosing and managing PH1 as early as possible is critical.1-5 Oxalate level evaluation and genetic testing are current approaches used to help inform a PH1 diagnosis.1,2

tests-to-establish
container mt-110 mob-mt-40 mb-40

GIVEN THE PROGRESSIVE, UNPREDICTABLE NATURE OF PH1, EARLY DIAGNOSIS IS CRITICAL5,6

If PH1 is suspected, some common methods seen in clinical practice to help test for the disease are listed below.

This testing information is provided for educational purposes only and is not intended to replace the independent medical judgment of any healthcare professional.

tests-to-establish
container-1330 measurement img_w-100

up-block d-flex

MEASURING OXALATE LEVELS

d-flex jc-space-around

In patients with preserved kidney function:

24-HOUR URINE TEST1,2,7,8*

  • Normal UOx level (all ages):
    <45 mg (<0.50 mmol) /1.73 m2/24 hours9
  • Spot testing can be used when 24-hour urine test is not possible6

In PH1, UOx levels are often >2 times higher than the upper limit normal.10

In patients with impaired kidney function:

PLASMA OXALATE MEASUREMENT2,3,6,8

  • Normal plasma oxalate level:
    ≤2.0 μmol/L†,11

Substantially elevated levels are typical when eGFR <30 mL/min/1.73 m2. Levels >50 μmol/L are suggestive of PH1.5

container container-970

In patients with elevated UOx or plasma oxalate levels:

GENETIC TESTING

Identifying AGXT gene mutations with genetic testing can help confirm a PH1 diagnosis with high sensitivity and specificity.2,8,12

It is recommended to screen family members of a patient with PH1, especially siblings.2,6

sm-box-grey-bg
container grey-bg mt-10 mb-10
genetic-testing-quote
container-970 mt-70 mb-70 mob-mt-40 mob-mb-40

The AUA recommends considering genetic testing to help confirm a PH1 diagnosis in any patient with urinary oxalate (UOx) excretion exceeding 75 mg/day (0.83 mmol/1.73 m2/day).‡,7


container container-970

*Values of UOx are laboratory- and method‑dependent.
Reference values have not been established for patients under 21 years old or greater than 81 years of age.11
In adults without bowel dysfunction.7

Download PH1 Diagnostic Considerations

container grey-bg mt-105 mob-mt-40 pb-70 mob-pb-40
container-970

Consider genetic testing2,5

Alnylam Act - Logo - Genetic Testing

One option for genetic testing when you suspect PH1 is the Alnylam Act® Program: Third-party genetic screening and counseling for patients who may have PH1 at no charge to patients, physicians, and payers.

The Alnylam Act® program was created to provide access to genetic testing and counseling to patients as a way to help people make more informed decisions about their health.

  • While Alnylam provides financial support for this program, tests and services are performed by independent third parties
  • Healthcare professionals must confirm that patients meet certain criteria to use the program
  • Alnylam receives de-identified patient data from this program, but at no time does Alnylam receive patient-identifiable information. Alnylam may use healthcare professional contact information for research purposes
  • Both genetic testing and genetic counseling are available in the US and Canada.
  • Healthcare professionals or patients who use this program have no obligation to recommend, purchase, order, prescribe, promote, administer, use, or support any Alnylam product.
  • No patients, healthcare professionals, or payers, including government payers, are billed for this program

Order a Test
Download this brochure to learn more about Alnylam Act®

container mt-105 mob-mt-40
hide container-970 video-playback-5

Early Diagnosis can mitigate damage1-5

Primary Hyperoxaluria Type 1 (PH1) in Children - Parents' Caregiving Perspectives - Video Thumbnail

Natalie and Jared share the hope they have for their children with PH1.

container linear-nav mt-105 mob-mt-40